Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients

Medical Oncology, 05/07/2012

The study indicates that hormonal receptor (HR) status and Ki67 index are predictors for pathologic complete response (pCR) but not for DFSdisease–free survival events (DFS) in HER2–positive patients with neoadjuvant trastuzumab/taxanes, which deserves further investigations.

Print Article Summary